|
| 36950681 | Modeling structure-activity relationships with machine learning to identify GSK3-targeted small molecules as potential COVID-19 therapeutics. | Front Endocrinol (Lausanne) | 2023 |
| 36950681 | Modeling structure-activity relationships with machine learning to identify GSK3-targeted small molecules as potential COVID-19 therapeutics. | Front Endocrinol (Lausanne) | 2023 |
| 34287999 | Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG-I-like receptors. | Med Res Rev | 2022 |
| 35456005 | Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action. | Cells | 2022 |
| 36142620 | Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach. | Int J Mol Sci | 2022 |
| 35990491 | Unraveling the Tomaralimab Epitope on the Toll-like Receptor 2 via Molecular Dynamics and Deep Learning. | ACS Omega | 2022 |
| 34287999 | Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG-I-like receptors. | Med Res Rev | 2022 |
| 35196855 | Novel Small-Molecule Inhibitor of NLRP3 Inflammasome Reverses Cognitive Impairment in an Alzheimer's Disease Model. | ACS Chem Neurosci | 2022 |
| 35456005 | Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action. | Cells | 2022 |
| 36142620 | Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach. | Int J Mol Sci | 2022 |
| 35990491 | Unraveling the Tomaralimab Epitope on the Toll-like Receptor 2 via Molecular Dynamics and Deep Learning. | ACS Omega | 2022 |
| 35196855 | Novel Small-Molecule Inhibitor of NLRP3 Inflammasome Reverses Cognitive Impairment in an Alzheimer's Disease Model. | ACS Chem Neurosci | 2022 |
| 32885758 | Origanum vulgare L.: In vitro Assessment of Cytotoxicity, Molecular Docking Studies, Antioxidant and Anti-inflammatory Activity in LPS Stimulated RAW 264.7 Cells. | Med Chem | 2021 |
| 37475994 | Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a <i>Mus musculus</i> Model. | J Rheum Dis | 2021 |
| 33803178 | Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook. | Int J Mol Sci | 2021 |
| 33997877 | Injectable <i>in situ</i> forming hydrogel gene depot to improve the therapeutic effect of STAT3 shRNA. | Biomater Sci | 2021 |
| 33946869 | Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication. | Cells | 2021 |
| 33562802 | A Cell-Penetrating Peptide That Blocks Toll-Like Receptor Signaling Protects Kidneys against Ischemia-Reperfusion Injury. | Int J Mol Sci | 2021 |
| 34206009 | Computational-Driven Epitope Verification and Affinity Maturation of TLR4-Targeting Antibodies. | Int J Mol Sci | 2021 |
| 34203170 | Molecular Basis for the Activation of Human Innate Immune Response by the Flagellin Derived from Plant-Pathogenic Bacterium, <i>Acidovorax avenae</i>. | Int J Mol Sci | 2021 |
| 32885758 | Origanum vulgare L.: In vitro Assessment of Cytotoxicity, Molecular Docking Studies, Antioxidant and Anti-inflammatory Activity in LPS Stimulated RAW 264.7 Cells. | Med Chem | 2021 |
| 33401508 | Functional Comparison between VP64-dCas9-VP64 and dCas9-VP192 CRISPR Activators in Human Embryonic Kidney Cells. | Int J Mol Sci | 2021 |
| 34671606 | Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies. | Front Cell Dev Biol | 2021 |
| 34901007 | CRISPR/Cas System and Factors Affecting Its Precision and Efficiency. | Front Cell Dev Biol | 2021 |
| 34502033 | Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations. | Int J Mol Sci | 2021 |
| 34604731 | Scaffold printing using biodegradable poly(1,4-butylene carbonate) ink: printability, <i>in vivo</i> physicochemical properties, and biocompatibility. | Mater Today Bio | 2021 |
| 34884569 | Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus. | Int J Mol Sci | 2021 |
| 34480409 | Endogenous Stem Cell-Based In Situ Tissue Regeneration Using Electrostatically Interactive Hydrogel with a Newly Discovered Substance P Analog and VEGF-Mimicking Peptide. | Small | 2021 |
| 37475994 | Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a <i>Mus musculus</i> Model. | J Rheum Dis | 2021 |
| 33562802 | A Cell-Penetrating Peptide That Blocks Toll-Like Receptor Signaling Protects Kidneys against Ischemia-Reperfusion Injury. | Int J Mol Sci | 2021 |
| 33803178 | Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook. | Int J Mol Sci | 2021 |
| 34884569 | Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus. | Int J Mol Sci | 2021 |
| 34901007 | CRISPR/Cas System and Factors Affecting Its Precision and Efficiency. | Front Cell Dev Biol | 2021 |
| 34502033 | Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations. | Int J Mol Sci | 2021 |
| 34671606 | Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies. | Front Cell Dev Biol | 2021 |
| 34604731 | Scaffold printing using biodegradable poly(1,4-butylene carbonate) ink: printability, <i>in vivo</i> physicochemical properties, and biocompatibility. | Mater Today Bio | 2021 |
| 34480409 | Endogenous Stem Cell-Based In Situ Tissue Regeneration Using Electrostatically Interactive Hydrogel with a Newly Discovered Substance P Analog and VEGF-Mimicking Peptide. | Small | 2021 |
| 34206009 | Computational-Driven Epitope Verification and Affinity Maturation of TLR4-Targeting Antibodies. | Int J Mol Sci | 2021 |
| 34203170 | Molecular Basis for the Activation of Human Innate Immune Response by the Flagellin Derived from Plant-Pathogenic Bacterium, <i>Acidovorax avenae</i>. | Int J Mol Sci | 2021 |
| 33946869 | Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication. | Cells | 2021 |
| 33997877 | Injectable <i>in situ</i> forming hydrogel gene depot to improve the therapeutic effect of STAT3 shRNA. | Biomater Sci | 2021 |
| 33401508 | Functional Comparison between VP64-dCas9-VP64 and dCas9-VP192 CRISPR Activators in Human Embryonic Kidney Cells. | Int J Mol Sci | 2021 |
| 31054927 | Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases. | Semin Cancer Biol | 2020 |
| 32325904 | A Computational Probe into the Structure and Dynamics of the Full-Length Toll-Like Receptor 3 in a Phospholipid Bilayer. | Int J Mol Sci | 2020 |
| 32023919 | TLR4-Targeting Therapeutics: Structural Basis and Computer-Aided Drug Discovery Approaches. | Molecules | 2020 |
| 32014819 | A peptide derived from the core β-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models. | EBioMedicine | 2020 |
| 32012718 | Toll-like Receptors from the Perspective of Cancer Treatment. | Cancers (Basel) | 2020 |
| 32012695 | The Roles of the NLRP3 Inflammasome in Neurodegenerative and Metabolic Diseases and in Relevant Advanced Therapeutic Interventions. | Genes (Basel) | 2020 |
| 32220799 | The αC helix of TIRAP holds therapeutic potential in TLR-mediated autoimmune diseases. | Biomaterials | 2020 |
| 33200028 | Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization. | Comput Struct Biotechnol J | 2020 |